Sarepta and Genethon Will Collaborate to Develop DMD Gene TherapyMuscular Dystrophy NewsSarepta Therpeutics and Genethon have signed a research collaboration agreement to jointly develop a gene therapy for Duchenne muscular dystrophy (DMD). Created by … Continue reading
AZoNano |
Dual-Cell Targeting Immunotherapy Nanoparticle Stimulates the Immune System to Hamper Tumor Growth
AZoNano Immunotherapy works by boosting the body’s own immune system in its fight against disease. Cancer patients have two main lines of immunotherapy: One that recruits the body’s T cells to destroy tumors, and the other that disables the ability of the … |
|
Focused Ultrasound Foundation and Cancer Research Institute Partner to Advance Cancer Immunotherapy
Newswise (press release) Newswise — Charlottesville, VA, and New York, NY – June 22, 2017 – The Focused Ultrasound Foundation (FUSF) and the Cancer Research Institute (CRI) are establishing a partnership with the goal of advancing the development of new focused ultrasound … |
|
French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy
Labiotech.eu (blog) Noble Généthon has teamed up with ignominious Sarepta to develop a gene therapy for the Duchenne variety of the muscle wasting disease. Dedicated to rare diseases since 1990 and more recently to gene therapy, Généthon is one of very few not-for-profit … |
|
French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy
Labiotech.eu (blog) Noble Généthon has teamed up with ignominious Sarepta to develop a gene therapy for the Duchenne variety of the muscle wasting disease. Dedicated to rare diseases since 1990 and more recently to gene therapy, Généthon is one of very few not-for-profit … |
|
French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy
Labiotech.eu (blog) Noble Généthon has teamed up with ignominious Sarepta to develop a gene therapy for the Duchenne variety of the muscle wasting disease. Dedicated to rare diseases since 1990 and more recently to gene therapy, Généthon is one of very few not-for-profit … |